𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug Development-targeted Screening of Leptin Agonist Glycopeptides

✍ Scribed by Daniel Knappe; Laszlo Otvos; Francesco De Pascali; Marco Cassone; Laura Scolaro; Giovanni Abbadessa; Cynthia Carrillo-Infante; Mohammad F. Kiani; Fred Donelson; Ralf Hoffmann; Eva Surmacz

Book ID
106452197
Publisher
Springer Netherlands
Year
2008
Tongue
English
Weight
276 KB
Volume
14
Category
Article
ISSN
1573-3149

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The screening of enzyme-targeted drugs
The screening of enzyme-targeted drugs
✍ C. L. Tsou πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

In this article C . L. Tsou, of the Institute of Biophysics, Beijing, criticizes the use of the expression I,,, the inhibitor concentration to produce 50% inhibition of a particular enzyme as a 'most unfortunate' parameter, when screening enzyme inhibitors designed as drugs. Comments on Dr Tsou's po

Development of a pharmacological target
Development of a pharmacological target profile for muscarinic agonists
✍ Daniel V. Widzowski; Paul Bialobok; Kris E. Kucera; Roberta Mihut; Shawn Sitar; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 178 KB

The purpose of these studies was to determine the levels of intrinsic activity in vitro at muscarinic receptor pharmacological subtypes (M 1 , M 2 , and M 3 ) that would optimize cognitive activity while minimizing acute adverse cholinergic effects in vivo. These levels of intrinsic efficacy at M 1